IMDX Competitors & Alternatives
Compare Insight Molecular Diagnostics Inc. with similar stocks in the same industry
Diagnostics & Research
IMDX
Main Stock$3.02
Tradestie Score
57
Market Cap
$94.16M
Revenue Growth
-0.5%
Analyst Upside
+173.2%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDNA
CareDx, Inc.
|
$70.74
|
$798.40M | 33.3 | 30 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.13
|
$719.31M | - | 63 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.57
|
$719.23M | - | 39 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.37
|
$667.77M | - | 57 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$15.92
|
$612.76M | - | 57 | Compare |
|
LCTX
Lineage Cell Therapeutics, Inc.
|
$0.95
|
$385.92M | - | 57 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$27.77
|
$62.81M | - | 53 | Compare |
|
AKTX
Akari Therapeutics plc ADR (0.01 USD)
|
$8.76
|
$31.97M | - | 50 | Compare |
|
SYBX
Synlogic, Inc. Common Stock
|
$0.56
|
$19.89M | - | 42 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$2.02
|
$4.78M | - | 57 | Compare |
More IMDX Analysis
Data updated: Oct 22, 2026 | Industry: Diagnostics & Research (SIC 2835)
40 stocks in this industry